INTRODUCTION
During the last few decades, milk production per dairy cow has increased, whereas reproductive efficiency has decreased (Lucy, 2001) . Given that nutrition greatly affects productive and reproductive functions (Butler, 2005) , nutritional strategies that promote milk production and concurrently benefit, or at least sustain, reproductive efficiency of dairy cows and heifers are warranted. As an example, inclusion of Ca salts of FA increased overall milk production of dairy cows (Erickson et al., 1992; Chouinard et al., 1997; Moallem et al., 2000) . Our research group demonstrated that supplementing Ca salts of PUFA during early gestation increased pregnancy rates in beef cows assigned to AI or embryo transfer by at least 10 percentage points (Lopes et al., 2009 (Lopes et al., , 2011 . Moreover, these reproductive benefits of PUFA supplementation to cattle were independent of its contribution to dietary energy content (Staples and Thatcher, 2005; Lopes et al., 2011) .
Beneficial postbreeding effects of PUFA include increased circulating progesterone (P4) concentrations (Grummer and Carroll, 1991; Lopes et al., 2009 ) and enhanced pregnancy maintenance (Spencer and Bazer, 2002; Lopes et al., 2011) . More specifically, PUFA have been shown to increase circulating P4 concentrations during early gestation by enhancing development of luteal cells (Lucy et al., 1991) and directly alleviating hepatic steroid metabolism (Sangsritavong et al., 2002) . Supplemental PUFA may also increase circulating insulin concentrations (Williams and Stanko, 2000) , which in turn has also been shown to reduce hepatic expression of P4 catabolic enzymes (Lemley et al., 2008; Vieira et al., 2010) and improve dairy reproductive function (Gong et al., 2002) . However, Ca salts of PUFA can be substantially dissociated and biohydrogenated when ruminal pH is below 6.0 (Sukhija and Palmquist, 1990) . In dairy cows receiving high-concentrate diets, ruminal pH can be rapidly reduced, and remain below 6.0 for several hours after feeding (Leedle et al., 1982) . Maekawa et al. (2002) reported the ruminal pH in dairy cows receiving high-concentrate TMR was greater than 6.0 before the morning feeding, remained above this level for at least 3 h after the morning feeding, but was less than 6.0 for the remainder of the day.
Based on this information, we hypothesized that feeding Ca salts of PUFA will benefit milk production and reproductive efficiency of dairy cows, and this outcome can be attributed, at least in part, to increased circulating P4 concentrations during early gestation. We also hypothesized that Ca salts of PUFA should be fed during the first feeding of the day to alleviate or prevent ruminal biohydrogenation and optimize the benefits of PUFA supplementation to dairy cows receiving high-concentrate diets. Hence, 2 experiments were conducted to evaluate milk production, milk composition, postbreeding serum concentrations of P4 and insulin, and reproductive performance of lactating Holstein cows receiving or not receiving Ca salts of PUFA (experiment 1), or receiving Ca salts of PUFA at different daily frequencies (experiment 2).
MATERIALS AND METHODS
Both experiments were conducted at a commercial dairy farm located in Araras, São Paulo, Brazil. The latitude, longitude, and altitude of this location are, respectively, 22°21 south, 47°23 west, and 614 m. Experiment 1 was conducted from April 2009 to March 2010, whereas experiment 2 was conducted from April 2010 to June 2011. The animals used were cared for in accordance with the practices outlined in the Guide for the Care and Use of Agricultural Animals in Agricultural Research and Teaching (FASS, 1999) . Across experiments, cows were maintained in freestall barns with access to an adjoining sod-based area. Barns were cooled by intermittent sprinkling and forced ventilation to minimize the effects of heat stress. Cows were milked 3 times daily in a side-by-side milking system (0400, 1200, and 2000 h).
Animals and Treatments
Experiment 1. A total of 1,125 primiparous (n = 376) and multiparous (n = 749) lactating Holstein cows (170 ± 3 DIM) randomly distributed in 10 freestall barns were enrolled in the experiment. Beginning in April 2009, freestall barns were assigned randomly to receive a high-concentrate diet containing (PF) or not containing (control, CON) 1.1% (DM basis) Ca salts of PUFA (Megalac-E; Química Geral do Nordeste, Rio de Janeiro, Brazil). Diets were offered as TMR 6 times daily (0400, 0600, 0800, 1200, 1500, and 2000 h), whereas the Ca salts of PUFA were included in the PF treatment in the first feeding of the day (0400 h; Table 1 ). The FA profile of treatments (Table 2) was estimated based on feed values provided by the CPM-Dairy model (Cornell-Penn-Miner Dairy, version 3.08.01; University of Pennsylvania, Kennett Square; Cornell University, Ithaca, NY; and William H. Miner Agricultural Research Institute, Chazy, NY), and the FA content of the Ca salts of PUFA provided by the manufacturer. Treatments were offered until March 2010, whereas cows remained in their original freestall barn throughout lactation. Within the cows enrolled in this experiment, a total of 691 animals (primiparous, n = 227; multiparous, n = 464) received treatments beginning at 30 DIM after being managed similarly during the initial 30 d postpartum, whereas the remaining 434 animals (primiparous, n = 149; multiparous, n = 285) began receiving treatments at greater DIM (170 ± 6 DIM).
Experiment 2. A total of 1,572 primiparous (n = 622) and multiparous (n = 950) lactating Holstein cows (155 ± 4 DIM) randomly distributed in 10 freestall barns were enrolled in the experiment. Beginning in April 2010, freestall barns were assigned randomly to receive a diet similar to PF in experiment 1 (Table  1) , but with Ca salts of PUFA included only in the first feeding of the day (0400 h; PF1X), or equally distributed across all feedings (PF6X). As in experiment 1, diets were offered as TMR 6 times daily (0400, 0600, 0800, 1200, 1500, and 2000 h), and the Ca salts of PUFA was included into both treatments at 1.1% (DM basis). Cows that were enrolled in experiment 1 receiving PF were automatically enrolled in experiment 2 as PF1X. Treatments were offered until June 2011, and cows remained in their original freestall barn throughout the lactation. Within the cows enrolled in this experiment, 1,085 animals (primiparous, n = 435; multiparous, n = 650) received treatments beginning at 30 DIM after being managed similarly during the initial 30 d postpartum, whereas the remaining 487 animals (primiparous, n = 187; multiparous, n = 300) began receiving treatments at greater DIM (187 ± 6 DIM).
Reproductive Management
During both experiments, cows that were >60 DIM were monitored for estrus using commercial pedometers (AfiTag; AfiMilk, Kibbutz Afikim, Israel), and artificially inseminated 12 h after the onset of estrus. Cows were inseminated by a single experienced technician using commercial frozen-thawed semen randomly chosen from 1 of 18 sires. A total of 1,739 AI were performed in 764 cows during experiment 1, whereas in experiment 2, 3,044 AI were performed in 1,133 cows. Pregnancy diagnosis was performed by detecting a viable conceptus with transrectal ultrasonography (Aloka SSD-500, 7.5 MHz linear-array transrectal transducer; Aloka Co. Ltd., Tokyo, Japan) 28 and 60 d after AI. Pregnancy loss was considered in cows that were pregnant on d 28 but nonpregnant on d 60 after AI.
During both experiments, cows (>60 DIM) that were not assigned AI or were diagnosed as nonpregnant (d 28 or 60 after AI) were assigned to an ovulation synchronization + fixed-time embryo transfer (FTET) protocol once a month. For the ovulation synchronization protocol (beginning on d −10), cows received a 100-μg injection of GnRH (Fertagyl; Schering-Plough Co., São Paulo, Brazil) and received an intravaginal P4 releasing device [controlled internal drug release (CIDR), containing 1.9 g of P4; Pfizer Animal Health, São Paulo, Brazil] on d −10, a 25-mg injection of PGF 2α (Lutalyse; Pfizer Animal Health) and CIDR removal on d −3, and a 1-mg injection of estradiol cypionate (ECP; Pfizer Animal Health) on d −2. Transrectal ultrasonography examinations (Aloka SSD-500, 7.5 MHz linear-array transrectal transducer) were performed in all recipient cows immediately before FTET (d 7) to verify presence of a corpus luteum. Only cows detected with a visible corpus luteum were assigned to embryo transfer (ET), which was performed with fresh Holstein embryos originated from in vivo procedures and obtained from a private company (Policlinica Pioneiros, Paraná, Brazil). Embryo collection and ET procedures were similar to those described by Vasconcelos et al. (2011) , and embryos originated from a combination of 75 donors (nonlactating heifers and cows) and 7 sires. Embryo transfer was performed by a single experienced technician and embryos were assigned randomly to recipient cows. A total of 978 FTET were performed in 632 cows during experiment 1, whereas in experiment 2, 1,171 FTET were performed in 697 cows. Pregnancy diagnosis was performed by detecting a viable conceptus with transrectal ultrasonography (Aloka SSD-500, 7.5 MHz linear-array transrectal transducer) on d 28 and 60. Pregnancy loss was considered in cows that were pregnant on d 28 but nonpregnant on d 60.
Sampling
During both experiments, daily milk yield for each cow was recorded automatically (AfiLite; AfiMilk), and averaged on a weekly basis. Milk samples were collected once per week from each cow during the first milking of the day (0400 h), and analyzed for fat and protein content using infrared spectrometry (method 972.16; AOAC International, 1999 ) by a commercial laboratory (Clínica do Leite; Universidade de São Paulo, Pi- Values were obtained from a commercial laboratory using wet chemistry analysis (Nutron, Campinas, Brazil).
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Calculated with the following equations (NRC, 2011): NE M = 1.37 ME − 0.138 ME 2 + 0.0105 ME 3 − 1.12; NE G = 1.42 ME − 0.174 ME 2 + 0.0122 ME 3 − 0.165, given that ME = 0.82 × DE, and 1 kg of TDN = 4.4 Mcal of DE. DE = digestible energy. Weiss et al. (1992) , whereas NE L and NE M were calculated with the equations proposed by the NRC (2001). In experiment 1, estimated duodenal flow of linoleic and linolenic acids were calculated based on DMI of each freestall barn, estimated FA profile of treatments (Table 2) , and the CPM-Dairy model (version 3.08.01), which has been shown to estimate intestinal FA flow adequately in cattle (Moate et al., 2004) . Blood samples were collected from cows assigned to and concurrently with FTET, via coccygeal vein or artery into commercial blood-collection tubes (Vacutainer, 10 mL; Becton Dickinson, Franklin Lakes, NJ), placed on ice immediately, maintained at 4°C for 12 h, and centrifuged at 1,500 × g for 15 min at 25°C for serum collection. Serum was stored at −20°C until analyzed for concentrations of insulin and P4 using Coat-A-Count solid-phase 125 I RIA kits (DPC Diagnostic Products Inc., Los Angeles, CA). Further, blood samples were only collected from cows that began receiving treatments at 30 DIM in both experiments. The intra-and interassay coefficients of variation were, respectively, 3.2 and 6.8%. The minimum detectable concentrations were 0.1 ng of P4/mL and 0.05 μIU of insulin/mL.
Statistical Analysis
In both experiments, performance parameters, serum variables, and services per pregnancy were analyzed with the MIXED procedure, whereas all other reproductive were analyzed with the GLIMMIX procedure (SAS Institute Inc., Cary, NC). All models used Satterthwaite approximation to determine the denominator degrees of freedom for the tests of fixed effects, freestall barn as the experimental unit, and cow (barn) and barn (treatment) as random variables. However, DMI, estimated duodenal flow of FA (experiment 1), and feed efficiency parameters were calculated from each freestall barn and according to the number of cows assigned to each barn; therefore, only barn (treatment) was included as random variable in these analyses. The model statement used for DIM, length of exposure to treatments before first service during the study (only cows assigned to study at DIM greater than 30 d), milk production, milk content, and serum variables of all cows assigned to the experiments contained the effects of treatment, parity, week or month (serum variables) of the study, and all resultant interactions. The model statement used for DMI, feed efficiency, nutrient intake, and duodenal flow of FA contained the effects of treatment, week of the study, and all resultant interactions. The model statement used for pregnancy status and loss per service contained the effects of treatment, parity, month of the study, technique (AI or FTET), and all resultant interactions. Within cows assigned to treatments beginning at 30 DIM, the model statement used for milk production and content contained the effects of treatment, parity, week of the lactation (first 43 wk), all resultant interactions, in addition to a repeated statement containing week as specified term, cow (barn) as subject, and autoregressive as covariance structure based on the Akaike information criterion. The model statement used for service per pregnancy contained the effects of treatment, parity, month of the study, and all resultant interactions. The model statement used for pregnancy attainment contained the effects of treatment, parity, week of pregnancy attainment, and all resultant interactions. All results are reported as least squares means ± standard error of the means and were separated using least significant difference. Significance was set at P ≤ 0.05, tendencies were determined if P > 0.05 and ≤0.10. Results are reported according to main effects if no interactions were significant, or according to the highest order interaction detected.
RESULTS AND DISCUSSION

Experiment 1
Performance parameters are reported in Table 3 . During the experimental period, DIM was similar (P = 0.89) between treatments. However, PF cows had greater (P = 0.04) milk yield, but had reduced (P < 0.01) milk fat content compared with CON cohorts during the experimental period. Hence, 3.5% FCM production during experiment 1 was similar (P = 0.61) between treatments, whereas no treatment effects were detected on milk fat yield (P = 0.61). Within cows assigned to treatments beginning at 30 DIM, treatment × week interactions were detected (P < 0.01) for milk yield and 3.5% FCM during the initial 43 wk of lactation. Cows receiving PF often had greater (P < 0.05) milk yield compared with CON cohorts beginning on wk 17 of lactation (Figure 1) , as well as greater (P < 0.05) FCM production ( Figure 2 ) beginning at wk 39 of lactation. Therefore, the improved milk production detected in PF cows during experiment 1 can be attributed, at least partially, to potential benefits of Ca salts of PUFA on lactation persistence. Supporting our results, previous research also reported enhanced milk production (Erickson et al., 1992; Chouinard et al., 1997; Moallem et al., 2000) , and reduced milk fat content (Chouinard et al., 1997; Selberg et al., 2004; Relling and Reynolds, 2007) when Ca salts of FA, including PUFA, were offered to dairy cows. Other authors also reported that feeding supplemental PUFA to dairy cows increased milk yield but did not change FCM production (Pantoja et al., 1996; AbuGhazaleh et al., 2004; Selberg et al., 2004) . Milk protein has also been shown to decrease in cows receiving Ca salts of FA (Erickson et al., 1992; Harrison et al., 1995; Chouinard et al., 1997) , although no treatment effects were detected herein for milk protein content (P = 0.45) or yield (P = 0.12). The benefits of Ca salts of FA supplementation on milk yield reported herein and by others is often attributed to increased energy intake in supplemented cows (Coppock and Wilks, 1991) , whereas the observed decrease in milk fat content is generally attributed to altered rumen function, biohydrogenation of Ca salts of FA, and ruminal formation of trans C18:1 FA (Bauman and Griinari, 2003) .
No treatment effects were detected on DMI (P = 0.56; Table 3) during the experiment. Based on DMI of each freestall barn and nutritional profile of treatments, no treatment effects were also detected (P ≥ 0.34) on average daily NE L and CP intake (Table 3) . These results indicate that inclusion of Ca salts of PUFA did not affect feed and subsequent nutrient intake. Previous studies also reported similar DMI between lactating dairy cows supplemented or not supplemented with Ca salts of FA, including PUFA (Holter et al., 1992; Schauff and Clark, 1992; . In fact, research has shown that DMI is not impaired in dairy cows receiving Ca salts of FA up to 5% of the diet (Moallem et al., 2000; Schroeder et al., 2003; Allred et al., 2006) , whereas the inclusion rate of the Ca salts of PUFA source used herein was 1.1% (DM basis). Although cows receiving PF in experiment 1 had increased milk production but similar nutrient and DMI compared with CON cohorts, no treatment effects were detected (P ≥ 0.23) on feed efficiency parameters (Table 3) . Other authors also reported that supplemental Ca salts of FA improved milk production without increasing DMI in lactating dairy cows (Erickson et al., 1992; Chouinard et al., 1997; Moallem et al., 2000) . Hence, it can be concluded that the production benefits associated with Ca salts of PUFA reported herein were independent of its potential contributions to energy, protein, and overall DMI, whereas further research is warranted to identify and properly understand these mechanisms.
Reproductive parameters are reported in Table 4 . Control and PF cows with DIM greater than 30 d at the beginning of the study were exposed to experimental procedures during a similar (P = 0.96; data not shown) timespan before the first service of the study (30.9 vs. 31.0 d, respectively; SEM = 2.2), which is adequate to modulate FA profile in reproductive tissues of dairy cattle (Mattos et al., 2000; Bilby et al., 2006) . For all reproductive variables analyzed, no treatment × reproductive technique (AI or FTET) interactions were detected; therefore, results were combined between both techniques. No treatment effects were detected (P ≥ 0.43) on pregnancy rates per service at d 28 or 60. However, pregnancy losses per service were reduced (P = 0.04) in PF cows compared with CON cohorts. Within pregnancy outcomes to the first service of each cow, no treatment effects were detected (P ≥ 0.45) on pregnancy status on d 28 and 60, whereas pregnancy loss tended (P = 0.10) to be less in PF cows compared with CON cohorts. Within cows assigned to treatments beginning at 30 DIM, no treatment effects were detected on pregnancy attainment (P = 0.68; data not shown), final pregnancy outcome (P = 0.51), or service per pregnancy (P = 0.22) during the experiment, although PF cows had reduced (P = 0.03) pregnancy loss upon the first service compared with CON cohorts. It is important to note that all reproductive outcomes were also analyzed with mean milk or FCM production during the week of service as covariates (data not shown); however, statistical outcomes were similar to those reported herein. These results suggest that feeding of Ca salts of PUFA to lactating dairy cows reduced pregnancy losses independent of its contribution to energy intake, although such benefit was not sufficient to increase pregnancy rates. Nevertheless, recent decreases in reproductive efficiency of dairy herds have been largely attributed to increased pregnancy losses (Zavy, 1994) , whereas more than 50% of dairy cows that conceive lose their pregnancy during the initial 6 wk of gestation (Santos et al., 2004) . Supporting the results reported herein, our research group recently reported that feeding of Ca salts of PUFA to beef cows after AI or ET increased pregnancy rates, whereas these outcomes were also independent of its contribution to energy intake, and attributed to enhanced pregnancy maintenance in supplemented cows (Lopes et al., 2009 (Lopes et al., , 2011 . It is also important to note that whole cottonseed was included at 6.0 and 11.9% of diet DM in PF and CON, respectively, whereas whole cottonseed has been shown to impair reproductive performance of dairy cows (Santos et al., 2003) . However, Villaseñor et al. (2008) reported that dairy heifers receiving a diet containing 11.7% of whole cottonseed had similar fertility parameters as well as embryo quality and development compared with cohorts not receiving whole cottonseed. Hence, treatment effects detected herein for pregnancy losses should not be associated with the reduced consumption of whole cottonseed by PF cows.
The mechanisms by which Ca salts of PUFA may reduce pregnancy losses include increased circulating P4 concentrations (Stronge et al., 2005; Demetrio et al., 2007) , modulation of PGF 2α synthesis and luteolysis (Williams and Stanko, 2000; Funston, 2004) , and enhanced maternal recognition of pregnancy (Wathes et al., 2007) . In regard to P4, this hormone prepares the uterine environment for conceptus growth and development, controls endometrial secretions and structural changes that are essential for proper embryo development (Gray et al., 2001; Wang et al., 2007) , modulates the release of hormones that may regress the corpus luteum and disrupt gestation such as PGF 2α (Bazer et al., 1998) , and is required for proper establishment of pregnancy (Spencer and Bazer, 2002) . In fact, P4 concentrations after breeding were positively associated with pregnancy rates in beef and dairy cattle (Robinson et al., 1989; Stronge et al., 2005; Demetrio et al., 2007) . Supplementation with PUFA increases circulating P4 by increasing circulating cholesterol availability, the major precursor for luteal P4 synthesis (Grummer and Carroll, 1991; Son et al., 1996) , as well as alleviating hepatic steroid metabolism (Hawkins et al., 1995; Sangsritavong et al., 2002; Lopes et al., 2009) . Moreover, Ca salts of PUFA may also increase circulating concentrations of insulin (Williams and Stanko, 2000) , which in turn has also been shown to reduce hepatic expression of P4 catabolic enzymes (Lemley et al., 2008) , enhance P4 synthesis by granulosa cells , and improve dairy reproductive function (Gong et al., 2002) . In the present experiment, however, a treatment × parity interaction was detected for serum insulin and P4 concentration in samples collected at the time of FTET (Table 5 ). Serum P4 concentration was greater (P < 0.01) and serum insulin concentration tended (P = 0.08) to be greater in primiparous cows receiving PF compared with CON cohorts on d 7 of the estrous cycle, whereas no treatment differences were detected within multiparous cows. Perhaps the inclusion rate of Ca salts of PUFA was sufficient to increase serum P4 and insulin in primiparous on d 7 relative to ovulation, but not in multiparous cows. Nevertheless, Ca salts of PUFA only increased serum P4 and insulin in primiparous cows, but reduced pregnancy loss per service independent of parity (treatment × parity interaction; P ≥ 0.36). Accordingly, research from our group also suggested that serum concentrations of P4 and insulin 7 d after ovulation might not be sufficient to fully explain the benefits of Ca salts of PUFA on pregnancy maintenance (Lopes et al., 2009 (Lopes et al., , 2011 . Therefore, these benefits may be associated with other mechanisms not evaluated herein, including modulation of luteolysis and enhanced maternal-fetal communication (Williams and Stanko, 2000; Funston, 2004; Wathes et al., 2007) . It is also important to note that the Ca salts of PUFA source offered herein and in our previous research with beef cows (Lopes et al., 2009 (Lopes et al., , 2011 contained significant amounts of linoleic and linolenic acids. According to the DMI of each freestall barn, estimated FA profile of treatments (Table 2) , and the CPM-Dairy model (version 3.08.01), the average daily duodenal flow of linoleic and linolenic acids per cow was greater (P < 0.01; data not shown) for PF compared with CON (73.3 vs. 50 .7 g of linoleic acid/d, SEM = 2.0; and 5.3 vs. 3.1 g of linolenic acid/d, SEM = 0.1; respectively). Linoleic acid can be desaturated and elongated to arachidonic acid and serve as a precursor for PGF 2α synthesis (Yaqoob and Calder, 2007) ; however, other studies also indicated that linoleic acid can reduce PGF 2α synthesis by inhibiting the enzymes Δ 6 -desaturase and cyclooxygenase (Staples et al., 1998; Cheng et al., 2001) . Conversely, linolenic acid is a precursor of eicosapentaenoic and docosahexaenoic acids, which have been shown to inhibit cyclooxygenase activity and, consequently, PGF 2α synthesis (Yaqoob and Calder, 2007) . Previous research demonstrated that supplementation with linoleic acid increased circulating concentrations of PGF 2α metabolite and reduced overall pregnancy rates (Filley et al., 2000; Grant et al., 2005) , whereas supplementation with linolenic acid inhibited synthesis of PGF 2α , delayed luteolysis, and reduced pregnancy losses in dairy and beef females Thatcher et al., 1997; Mattos et al., 2000) . Given that the amount and type of FA reaching target tissues dictates whether pregnancy is maintained or not , it cannot be concluded if Ca salts of PUFA decreased pregnancy losses herein due to the increased supply of linoleic acid, linolenic acid, or both. Moreover, the same rationale should be applied to the benefits of Ca salts of PUFA on milk production parameters reported in the present experiment. Consequently, further research is still warranted to determine the dietary levels and ratio of linoleic and linolenic acids required to effectively benefit productive and reproductive function in dairy cows.
Experiment 2
Performance parameters are reported in Table 6 . During the experimental period, mean DIM was similar (P = 0.87) between treatments, whereas no treatment differences were detected (P ≥ 0.39) on milk content and production parameters, including within cows assigned to treatments beginning at 30 DIM (P ≥ 0.56; data not shown). Hence, increasing the frequency of feeding Ca salts of PUFA did not affect milk production or composition. No treatment effects were detected on DMI (P = 0.96) during the experiment, indicating that PF1X and PF6X cows consumed the same (P = 0.96) daily amount of Ca soaps of PUFA (0.250 vs. 0.251 kg/d for PF1X and PF6X, respectively; SEM = 0.007). Similarly to experiment 1, no treatment effects were detected (P ≥ 0.76) on average daily NE L and CP intake, as well as on feed efficiency parameters (Table 6 ), suggesting that frequency of Ca salts of PUFA inclusion in the TMR did not affect nutrient intake and utilization. Therefore, Ca salts of PUFA can be fed once per day, or included in every TMR feeding, without affecting feed intake and overall production parameters of lactating dairy cows (Coppock and Wilks, 1991; Bauman and Griinari, 2003) . Reproductive parameters are reported in Table 7 . As in experiment 1, PF1X and PF6X cows with DIM greater than 30 d at the beginning of the study were exposed to experimental procedures during a similar (P = 0.93; data not shown) timespan before the first service of the study (26.1 vs. 26.4 d, respectively; SEM = 2.2), which is adequate to modulate FA profile in reproductive tissues of dairy cattle (Mattos et al., 2000; Bilby et al., 2006) . No treatment × reproductive technique (AI or FTET) interactions were detected; therefore, results were combined between both techniques. No treatment effects were detected (P ≥ 0.45) on pregnancy rates per service at d 28 or 60. However, pregnancy losses per service tended (P = 0.09) to be reduced in PF1X cows compared with PF6X cohorts. Within pregnancy outcomes to the first service of each cow, no treatment effects were detected (P ≥ 0.41) on pregnancy status on d 28 and 60 or pregnancy loss. No treatment effects were detected on pregnancy attainment (P = 0.60; data not shown), final pregnancy outcome (P = 0.48), service per pregnancy (P = 0.22), or pregnancy loss (P ≥ 0.21) within cows assigned to treatments beginning at 30 DIM during experiment 2. These results suggest that reducing the feeding frequency of Ca salts of PUFA to lactating dairy cows benefited reproduction by reducing pregnancy losses. Moreover, this reproductive benefit was independent of nutrient intake and milk production, but not sufficient to increase pregnancy rates. One can speculate that feeding Ca salts of PUFA during the first feeding of the day alleviated ruminal dissociation and consequent biohydrogenation of these FA. Calcium salts of PUFA can be substantially dissociated and biohydrogenated when ruminal pH is below 6.0 (Sukhija and Palmquist, 1990) , whereas ruminal pH in dairy cows receiving high-concentrate TMR may be greater than 6.0 before and for the first hours after the morning feeding (Maekawa et al., 2002) . Hence, PF1X cows may have experienced greater absorption and incorporation of PUFA compared with PF6X cohorts, leading to treatment differences detected for pregnancy loss per service. However, rumen pH, ruminal biohydrogenation, and PUFA concentrations in serum or tissues were not evaluated herein to support these assumptions.
No treatment effects were detected on serum P4 (P = 0.31; data not shown) or insulin (P = 0.94; data not shown) concentrations (3.44 vs. 3.58 ng of P4/mL, SEM = 0.10; and 7.2 vs. 7.0 μUI of insulin/mL, SEM = 1.2, for PF1X and PF6X cows, respectively) in samples collected at the time of FTET. The results indicate that frequency of Ca salts of PUFA inclusion into the TMR did not affect circulating concentrations of these hormones on d 7 of the estrous cycle. Similarly to experiment 1, the decrease in pregnancy loss per service detected herein was independent of treatment effects The Ca salts of PUFA used were Megalac-E (Química Geral do Nordeste, Rio de Janeiro, Brazil).
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Milk production was recorded and collected daily, whereas milk samples were analyzed weekly for fat and protein content, from each freestall barn (n = 5/treatment) during the experimental period (April 2009 to March 2010). The Ca salts of PUFA used were Megalac-E (Química Geral do Nordeste, Rio de Janeiro, Brazil). Pregnancy outcomes to the first service after calving.
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Final pregnancy rates during the experimental period, and number of services required per pregnancy in cows assigned to treatments beginning at 30 DIM.
